Litigation is moving forward against the makers of Pradaxa. More than 100 suits have been filed and the first cases have been scheduled, despite a recent safety review from the Food and Drug Administration concluding that the anticoagulant medicine does ...Read More »
The Food and Drug Administration’s expedited approval of drugs like the blood thinner Pradaxa may be endangering U.S. consumers, according to a new column in the Journal of the American Medical Association.Read More »
The anti-nausea drug Reglan and its generic counterparts were the drugs most frequently cited in litigation in 2011, according to a consumer watchdog’s latest analysis of Food and Drug Administration statistics.
Tagged with: Accutane adverse events Avandia Bayer Chantix Coumadin drug litigation FDA Food and Drug Administration GlaxoSmithKline Hoffman-LaRoche Institute for Safe Medication Practices Johnson & Johnson Levaquin Pfizer Pradaxa prescription drugs Reglan Wyeth Yasmin YazRead More »
What are believed to be the first three product liability suits over the blood thinner Pradaxa were filed earlier this month in federal courts in Kentucky, Louisiana and Tennessee.Read More »